Gilead scraps late-stage trial of blood cancer treatment – Reuters

Magrolimab is also in development for other types of cancer such as acute myeloid leukemia and solid tumours. Reporting by Sriparna Roy in Bengaluru …

Share on Facebook

Tweet

Follow us

Save